Revolutionary self-folding nanoscale MRI agent sharpens cancer imaging

Study introduces a novel self-folding nanoscale contrast agent for MRI, enhancing tumor visualization with lower gadolinium loads and reduced risk of adverse effects.

Titrzepatide reduces risk of death or worsening heart failure for patients with obesity-related heart failure

Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure, preserved heart pump function and

November 21, 2024

Upcoming Studies on Dupilumab for Alopecia Areata

Two studies will explore the effectiveness and safety of dupilumab (Dupixent) in patients with alopecia areata. In this exclusive MedPage Today video, Emma Guttman, MD,

September 28, 2023

Shield Therapeutics (STX) Investor Forum – Biotech Investments

Hardman & Co Research Hardman & Co Video Event: Shield Therapeutics (STX) Investor Forum 11-Nov-2024 / 14:00 GMT/BST The issuer is solely responsible for the

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.